Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Development of a method for the preparation of zirconium-89 radiolabelled chitosan nanoparticles as an application for leukocyte trafficking with positron emission tomography.

Fairclough M, Ellis B, Boutin H, Jones AKP, McMahon A, Alzabin S, Gennari A, Prenant C.

Appl Radiat Isot. 2017 Sep 6;130:7-12. doi: 10.1016/j.apradiso.2017.09.004. [Epub ahead of print]

PMID:
28923298
2.

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes.

Bystrom J, Clanchy FI, Taher TE, Al-Bogami MM, Muhammad HA, Alzabin S, Mangat P, Jawad AS, Williams RO, Mageed RA.

Clin Rev Allergy Immunol. 2017 May 9. doi: 10.1007/s12016-017-8610-y. [Epub ahead of print]

PMID:
28488248
3.

Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.

Hull DN, Williams RO, Pathan E, Alzabin S, Abraham S, Taylor PC.

Clin Exp Immunol. 2015 Sep;181(3):401-6. doi: 10.1111/cei.12626. Epub 2015 Jun 23.

4.

Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).

Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J.

PLoS Pathog. 2013 Sep;9(9):e1003627. doi: 10.1371/journal.ppat.1003627. Epub 2013 Sep 12.

5.

Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance.

Alzabin S, Kong P, Medghalchi M, Palfreeman A, Williams R, Sacre S.

Arthritis Res Ther. 2012 Jun 12;14(3):R142. doi: 10.1186/ar3875.

6.

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.

Alzabin S, Abraham SM, Taher TE, Palfreeman A, Hull D, McNamee K, Jawad A, Pathan E, Kinderlerer A, Taylor PC, Williams R, Mageed R.

Ann Rheum Dis. 2012 Oct;71(10):1741-8. doi: 10.1136/annrheumdis-2011-201024. Epub 2012 May 1.

PMID:
22550316
7.

Etiology of autoimmune disease: past, present and future.

Alzabin S, Venables PJ.

Expert Rev Clin Immunol. 2012 Feb;8(2):111-3. doi: 10.1586/eci.11.88. Review. No abstract available.

PMID:
22288447
8.

Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic mice.

Kinloch AJ, Alzabin S, Brintnell W, Wilson E, Barra L, Wegner N, Bell DA, Cairns E, Venables PJ.

Arthritis Rheum. 2011 Dec;63(12):3818-23. doi: 10.1002/art.30639.

9.

Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists.

Lallemand C, Kavrochorianou N, Steenholdt C, Bendtzen K, Ainsworth MA, Meritet JF, Blanchard B, Lebon P, Taylor P, Charles P, Alzabin S, Tovey MG.

J Immunol Methods. 2011 Oct 28;373(1-2):229-39. doi: 10.1016/j.jim.2011.08.022. Epub 2011 Sep 3.

PMID:
21910993
10.

Effector T cells in rheumatoid arthritis: lessons from animal models.

Alzabin S, Williams RO.

FEBS Lett. 2011 Dec 1;585(23):3649-59. doi: 10.1016/j.febslet.2011.04.034. Epub 2011 Apr 19. Review.

11.

IL-17 induces hyperalgesia via TNF-dependent neutrophil infiltration.

McNamee KE, Alzabin S, Hughes JP, Anand P, Feldmann M, Williams RO, Inglis JJ.

Pain. 2011 Aug;152(8):1838-45. doi: 10.1016/j.pain.2011.03.035. Epub 2011 Apr 19.

PMID:
21507574
12.

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.

Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA.

Nat Immunol. 2011 Mar;12(3):231-8. doi: 10.1038/ni.1990. Epub 2011 Jan 16.

PMID:
21240265
13.

CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response.

Simelyte E, Alzabin S, Boudakov I, Williams R.

Clin Exp Immunol. 2010 Oct;162(1):163-8. doi: 10.1111/j.1365-2249.2010.04227.x.

14.

Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response.

Alzabin S, Pyarajan S, Yee H, Kiefer F, Suzuki A, Burakoff S, Sawasdikosol S.

Cancer Immunol Immunother. 2010 Mar;59(3):419-29. doi: 10.1007/s00262-009-0761-0. Epub 2009 Sep 29.

15.

Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation.

Alzabin S, Bhardwaj N, Kiefer F, Sawasdikosol S, Burakoff S.

J Immunol. 2009 May 15;182(10):6187-94. doi: 10.4049/jimmunol.0802631.

16.

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells.

Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO.

J Exp Med. 2008 Oct 27;205(11):2491-7. doi: 10.1084/jem.20072707. Epub 2008 Oct 20.

17.

Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway.

Sawasdikosol S, Pyarajan S, Alzabin S, Matejovic G, Burakoff SJ.

J Biol Chem. 2007 Nov 30;282(48):34693-9. Epub 2007 Sep 25.

18.

Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.

Pérez de Castro I, Benet M, Jiménez M, Alzabin S, Malumbres M, Pellicer A.

Cancer Res. 2005 Apr 15;65(8):3249-56.

Supplemental Content

Loading ...
Support Center